Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PSD502 vs Placebo in Premature Ejaculation
NCT03578783Phase 2Completed
- Sponsor
- Plethora Solutions
- Start
- Dec 2018
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in premature ejaculation (PE) comparing PSD502 with Placebo (2 arms). Primary endpoint: Change between Baseline and 4 weeks in Success on the Premature Ejaculation Bothersome Evaluation Questionnaire Item 3 (event-specific bother). Started Dec 2018; status: completed.
02
Drugs
Fortacin
03
Conditions
premature ejaculation (PE)
Beyond the preview
Go deeper on NCT03578783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03578783.